BC-12-VG35_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, N-{3-[6-(3,6-Dihydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-5-fluoro-2-methyl-phenyl}-2-fluoro-4-(1-hydroxy-1-methyl-ethyl)-benzamide, reversible BTK inhibitor targeting BTK (Novartis, 71230655)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/71230655
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the BC-12-VG35_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RUVBL2 RuvB-like AAA ATPase 2 0.457657
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.383561
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 0.359272
RPS15A ribosomal protein S15a 0.332126
RPS3 ribosomal protein S3 0.283879
RPL11 ribosomal protein L11 0.25529
RPL35 ribosomal protein L35 0.24915
KIF19 kinesin family member 19 0.234215
NOP56 NOP56 ribonucleoprotein 0.234215
C19ORF33 chromosome 19 open reading frame 33 0.218475
PRDX2 peroxiredoxin 2 0.214917

decreased expression

Symbol Name Standardized Value
ZDHHC16 zinc finger, DHHC-type containing 16 -0.234215
MSX1 msh homeobox 1 -0.234215